Marker Therapeutics is highly rated by Canaccord Genuity for its innovative cancer cell therapies, aiming for an target price from . Krystal Biotech garners a strong buy from Jefferies, targeting…
Danaher Corporation leads in bioprocessing and lab technologies, with stocks rising to $209.86, attracting investor interest through innovative life-saving therapeutics. AbbVie Inc.'s stock price reaches $202.03, driven by pharmaceutical breakthroughs…
Virginia allocates $4.9 million to Project VITAL to enhance life sciences innovation. Virginia Tech leads the initiative, aiming to transform breakthrough ideas into medical advancements. Funding from the GO Virginia…
IPOs offer lucrative investment opportunities in the public market. Expert guidance, like that from Donovan Jones at IPO Edge, can reveal valuable insights. Accessing IPO filings and calendars is crucial…